• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prader-Willi 综合征患者 COVID-19 严重程度低的矛盾现象:来自法国对 647 例患者的调查数据。

Paradoxical low severity of COVID-19 in Prader-Willi syndrome: data from a French survey on 647 patients.

机构信息

Assistance Publique-Hôpitaux de Paris, Centre de référence Maladies Rares (PRADORT, Syndrome de Prader-Willi et autres formes rares d'obésité avec troubles du comportement alimentaire), Service de Nutrition, Hôpital Pitié-Salpêtrière, ENDO-ERN (European Reference Network on Rare Endocrine Conditions), 47-83 boulevard de l'Hôpital, 75651, Paris Cedex 13, France.

Assistance Publique-Hôpitaux de Paris, Centre de référence Maladies Rares (PRADORT, Syndrome de Prader-Willi et autres formes rares d'obésité avec troubles du comportement alimentaire), Hôpital Marin d'Hendaye, ENDO-ERN (European Reference Network on Rare Endocrine Conditions), Hendaye, France.

出版信息

Orphanet J Rare Dis. 2021 Jul 21;16(1):325. doi: 10.1186/s13023-021-01949-4.

DOI:10.1186/s13023-021-01949-4
PMID:34289876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8294211/
Abstract

BACKGROUND

Patients with Prader-Willi syndrome (PWS) often have comorbidities, especially obesity, that may constitute a risk factor for severe forms of COVID-19. We aimed to assess prevalence and medical course of SARS-CoV-2 infection in children and adults with PWS. From November 2020 to January 2021, we performed a detailed medical survey on 342 adults and 305 children with PWS followed in the French reference center.

RESULTS

We obtained responses from 288 adults (84%) and 239 children (78%). From March 2020 to January 2021, 38 adults (13.2%) and 13 children (5.4%) with PWS had SARS-CoV-2 infection. Mean age of adults was 34.1 ± 11.9 years and mean body mass index was 40.6 ± 12.7 kg/m; 82% had obesity and 37% had diabetes. Only 3 children (23%) had obesity and none had diabetes. Similar to the general population, the most frequent symptoms of COVID-19 were asthenia, fever, cough, headache and shortness of breath. All patients had a favorable outcome.

CONCLUSION

PWS itself is not a risk factor for severe COVID-19 in children and adults. On the contrary, evolution of SARS-CoV-2 infection in adults with PWS seems more favorable than expected, given their comorbidities.

摘要

背景

普拉德-威利综合征(PWS)患者常合并多种疾病,尤其是肥胖症,这可能构成 COVID-19 重症的危险因素。我们旨在评估 PWS 儿童和成人中 SARS-CoV-2 感染的流行情况和病程。自 2020 年 11 月至 2021 年 1 月,我们对法国参考中心随访的 342 名成人和 305 名儿童进行了详细的医学调查。

结果

我们获得了 288 名成人(84%)和 239 名儿童(78%)的回复。自 2020 年 3 月至 2021 年 1 月,38 名成人(13.2%)和 13 名儿童(5.4%)患有 SARS-CoV-2 感染。成人的平均年龄为 34.1±11.9 岁,平均体重指数为 40.6±12.7 kg/m;82%肥胖,37%患有糖尿病。仅有 3 名儿童(23%)肥胖,无一例患有糖尿病。与一般人群一样,COVID-19 的最常见症状为乏力、发热、咳嗽、头痛和呼吸急促。所有患者均预后良好。

结论

PWS 本身不是儿童和成人 COVID-19 重症的危险因素。相反,考虑到 PWS 成人的合并症,SARS-CoV-2 感染在成人中的病程似乎比预期更为有利。

相似文献

1
Paradoxical low severity of COVID-19 in Prader-Willi syndrome: data from a French survey on 647 patients.Prader-Willi 综合征患者 COVID-19 严重程度低的矛盾现象:来自法国对 647 例患者的调查数据。
Orphanet J Rare Dis. 2021 Jul 21;16(1):325. doi: 10.1186/s13023-021-01949-4.
2
The presentation, course and outcome of COVID-19 infection in people with Prader-Willi syndrome: unexpected findings from an international survey.普瑞德威利氏症候群患者之 COVID-19 感染之临床表现、病程与转归:国际调查之意外发现。
Orphanet J Rare Dis. 2022 Feb 21;17(1):69. doi: 10.1186/s13023-022-02228-6.
3
Cross-cultural comparisons of obesity and growth in Prader-Willi syndrome.普拉德-威利综合征中肥胖与生长的跨文化比较。
J Intellect Disabil Res. 2008 May;52(Pt 5):426-36. doi: 10.1111/j.1365-2788.2008.01044.x. Epub 2008 Feb 20.
4
Effects of the COVID-19 pandemic and lockdown on the mental and physical health of adults with Prader-Willi syndrome.COVID-19 大流行和封锁对成年普拉德-威利综合征患者身心健康的影响。
Orphanet J Rare Dis. 2021 May 5;16(1):202. doi: 10.1186/s13023-021-01833-1.
5
Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.普瑞德威利综合征 2 型糖尿病的患病率及危险因素:单中心经验
Orphanet J Rare Dis. 2017 Aug 30;12(1):146. doi: 10.1186/s13023-017-0702-5.
6
Metabolic syndrome in adult patients with Prader-Willi syndrome.成年普拉德-威利综合征患者的代谢综合征。
Nutr Metab Cardiovasc Dis. 2013 Nov;23(11):1134-40. doi: 10.1016/j.numecd.2012.11.006. Epub 2012 Dec 7.
7
Behavioural change in Prader-Willi syndrome during COVID-19 pandemic.普瑞德威利氏症候群患者在 COVID-19 大流行期间的行为改变。
J Intellect Disabil Res. 2021 Jul;65(7):609-616. doi: 10.1111/jir.12831. Epub 2021 Mar 22.
8
Causes of death in Prader-Willi syndrome: lessons from 11 years' experience of a national reference center.普拉德-威利综合征的死因:国家参考中心 11 年经验教训。
Orphanet J Rare Dis. 2019 Nov 4;14(1):238. doi: 10.1186/s13023-019-1214-2.
9
The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.生长激素治疗普拉德-威利综合征儿童及青少年的行为影响:一项为期2年的对照研究。
Pediatrics. 2002 Feb;109(2):E35. doi: 10.1542/peds.109.2.e35.
10
Grey matter volume and cortical structure in Prader-Willi syndrome compared to typically developing young adults.与典型发育的年轻成年人相比,普拉德-威利综合征的灰质体积和皮质结构。
Neuroimage Clin. 2017 Dec 20;17:899-909. doi: 10.1016/j.nicl.2017.12.027. eCollection 2018.

引用本文的文献

1
Inpatient Hospitalizations for COVID-19 Among Patients With Prader-Willi Syndrome: A National Inpatient Sample Analysis.普拉德-威利综合征患者中因新冠病毒疾病(COVID-19)的住院情况:一项全国住院患者样本分析
Am J Med Genet A. 2025 May;197(5):e63980. doi: 10.1002/ajmg.a.63980. Epub 2025 Jan 11.
2
Retrospective longitudinal study on the long-term impact of COVID-19 infection on polysomnographic evaluation in patients with Prader-Willi syndrome.关于新冠病毒感染对普拉德-威利综合征患者多导睡眠图评估的长期影响的回顾性纵向研究。
Orphanet J Rare Dis. 2024 Dec 13;19(1):461. doi: 10.1186/s13023-024-03447-9.
3
Inpatient Hospitalizations for COVID-19 Among Patients with Prader-Willi Syndrome: a National Inpatient Sample Analysis.普拉德-威利综合征患者中因新冠病毒病住院治疗情况:一项全国住院患者样本分析
medRxiv. 2024 Sep 6:2024.09.06.24313191. doi: 10.1101/2024.09.06.24313191.
4
Causal associations between COVID-19 and childhood mental disorders.新冠病毒与儿童精神障碍之间的因果关系。
BMC Psychiatry. 2023 Dec 8;23(1):922. doi: 10.1186/s12888-023-05433-0.
5
Associations and Disease-Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review.COVID-19 与先天性和遗传疾病的关联及疾病间相互作用:全面综述。
Viruses. 2022 Apr 27;14(5):910. doi: 10.3390/v14050910.

本文引用的文献

1
Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?选择性 5-羟色胺再摄取抑制剂的药物再利用:这些药物能帮助对抗 COVID-19 并拯救生命吗?
J Clin Neurosci. 2021 Jun;88:163-172. doi: 10.1016/j.jocn.2021.03.010. Epub 2021 Mar 19.
2
Effects of the COVID-19 pandemic and lockdown on the mental and physical health of adults with Prader-Willi syndrome.COVID-19 大流行和封锁对成年普拉德-威利综合征患者身心健康的影响。
Orphanet J Rare Dis. 2021 May 5;16(1):202. doi: 10.1186/s13023-021-01833-1.
3
Risk factors for poor outcomes in hospitalised COVID-19 patients: A systematic review and meta-analysis.住院 COVID-19 患者不良结局的危险因素:系统评价和荟萃分析。
J Glob Health. 2021 Mar 1;11:10001. doi: 10.7189/jogh.11.10001.
4
Behavioural change in Prader-Willi syndrome during COVID-19 pandemic.普瑞德威利氏症候群患者在 COVID-19 大流行期间的行为改变。
J Intellect Disabil Res. 2021 Jul;65(7):609-616. doi: 10.1111/jir.12831. Epub 2021 Mar 22.
5
Association of Vitamin D Status With Hospital Morbidity and Mortality in Adult Hospitalized Patients With COVID-19.维生素D状态与成人COVID-19住院患者医院发病率和死亡率的关联
Endocr Pract. 2021 Apr;27(4):271-278. doi: 10.1016/j.eprac.2021.02.013. Epub 2021 Mar 9.
6
Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction.普拉德-威利综合征中的内分泌紊乱:理解和治疗下丘脑功能障碍的模型
Lancet Diabetes Endocrinol. 2021 Apr;9(4):235-246. doi: 10.1016/S2213-8587(21)00002-4. Epub 2021 Feb 26.
7
Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey.唐氏综合征患者对重症 COVID-19 的医学易感性——来自 21 三体研究协会和英国 ISARIC4C 调查的数据
EClinicalMedicine. 2021 Mar;33:100769. doi: 10.1016/j.eclinm.2021.100769. Epub 2021 Feb 22.
8
Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study.抗抑郁药的使用与 COVID-19 住院患者插管或死亡风险降低的关联:一项观察性研究的结果。
Mol Psychiatry. 2021 Sep;26(9):5199-5212. doi: 10.1038/s41380-021-01021-4. Epub 2021 Feb 4.
9
COVID-19 in patients with Down syndrome.唐氏综合征患者的 COVID-19 感染。
Neurol Sci. 2021 May;42(5):1649-1652. doi: 10.1007/s10072-021-05091-8. Epub 2021 Feb 1.
10
Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population.不要忽视中年人群中感染新冠病毒后的住院和死亡风险。
Infect Dis Now. 2021 Jun;51(4):380-382. doi: 10.1016/j.idnow.2020.12.007. Epub 2021 Jan 18.